Showing results (51-60 of 272) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancerAndrea B Apolo, Jamie Riches, Heiko Schöder, et al.
Urologic Oncology|November 4, 2015
Stage at presentation and survival outcomes of patients with Gleason 8-10 prostate cancer and low prostate-specific antigenAaron D Falchook, Neil E Martin, Ramsankar Basak, et al.
The Oncologist|April 26, 2017
A Systematic Review of Strategies to Prevent Cisplatin-Induced NephrotoxicityDaniel J Crona, Aimee Faso, Tomohiro F Nishijima, et al.
JAMA Oncology|July 17, 2015
Improving Patient Safety in Clinical Oncology: Applying Lessons From Normal Accident TheoryBhishamjit S Chera, Lukasz Mazur, Ian Buchanan, et al.
BJU International|November 14, 2013
Association of hospital volume with conditional 90-day mortality after cystectomy: an analysis of the National Cancer Data BaseMatthew E Nielsen, Katherine Mallin, Mark A Weaver, et al.
Journal of Cellular and Molecular Medicine|December 16, 2010
Two sides to every story: the HIF-dependent and HIF-independent functions of pVHLMingqing Li, William Y Kim
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2023
Viewing RCC with a DNA Methylation Lens ENHANCES Understanding of ICI ResistanceMi Zhou, William Y Kim
Clinical Genitourinary Cancer|May 30, 2006
Clinical utility of radiolabeled monoclonal antibodies in prostate cancerKevin A David, Matthew I Milowsky, Lale Kostakoglu, et al.
European Urology|December 13, 2023
Spatial Relationships in the Tumor Microenvironment Demonstrate Association with Pathologic Response to Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder CancerWolfgang Beckabir, Sara E Wobker, Jeffrey S Damrauer, et al.
The Journal of Urology|November 12, 2003
Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigenDavid M Nanus, Matthew I Milowsky, Lale Kostakoglu, et al.
Pageof 28